{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T22:35:51Z","timestamp":1774996551784,"version":"3.50.1"},"reference-count":41,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The role of the hematologist in the management of vascular anomalies is evolving. Several vascular tumors and malformations are associated with complex coagulation derangements. Kaposiform hemangioendothelioma or tufted angiomas may present with a consumptive coagulopathy known as the Kasabach-Merritt phenomenon (KMP). The management of KMP is essential to reduce morbidity and mortality from this condition. Slow-flow vascular malformations (SFVM) are also frequently complicated by a coagulopathy requiring anticoagulation, especially during and after surgical procedures, and some of these conditions pose a high risk of venous thromboembolism. Pain in SFVM is also frequently responsive to anticoagulation as well. It is essential for a hematologist with expertise in vascular anomalies to assist in the management of these complex conditions as part of a multidisciplinary team to reduce morbidity and mortality. Through case-based discussions, we attempt to highlight the critical role of the hematologist in managing these anomalies.<\/jats:p>","DOI":"10.1182\/hematology.2024000597","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T15:06:48Z","timestamp":1733497608000},"page":"718-723","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Hemostasis and thrombosis risks and management in vascular anomalies"],"prefix":"10.1182","volume":"2024","author":[{"given":"Shelley E.","family":"Crary","sequence":"first","affiliation":[{"name":"Pediatric Hematology-Oncology, University of Arkansas for Medical Sciences, Little Rock, AR"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"2024121115404884000_hem2024000597C1","unstructured":"International Society for the Study of Vascular Anomalies. Classification. issva.org\/classification. Accessed 7August2024."},{"issue":"3","key":"2024121115404884000_hem2024000597C2","doi-asserted-by":"crossref","first-page":"102402","DOI":"10.1016\/j.rpth.2024.102402","article-title":"Anticoagulation and vascular anomalies","volume":"8","author":"Crary","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"2024121115404884000_hem2024000597C3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpeds.2012.06.044","article-title":"Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals","volume":"162","author":"Croteau","year":"2013","journal-title":"J Pediatr"},{"issue":"2","key":"2024121115404884000_hem2024000597C4","first-page":"457","article-title":"Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon","volume":"179","author":"Ji","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"2024121115404884000_hem2024000597C5","doi-asserted-by":"crossref","first-page":"e30779","DOI":"10.1002\/pbc.30779","article-title":"Treatment practices and response in kaposiform hemangioendothelioma: a multicenter cohort study","volume":"71","author":"Borst","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2024121115404884000_hem2024000597C6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1525-1470.1999.00103.x","article-title":"Kasabach-Merritt syndrome: identification of platelet trapping in a tufted angioma by immunohistochemistry technique using monoclonal antibody to CD61","volume":"16","author":"Seo","year":"1999","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"2024121115404884000_hem2024000597C7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13023-020-1320-1","article-title":"Kaposiform hemangioendothelioma: current knowledge and future perspectives","volume":"15","author":"Ji","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2024121115404884000_hem2024000597C8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jpeds.2013.03.080","article-title":"Consensus-derived practice standards plan for complicated kaposiform hemangioendothelioma","volume":"163","author":"Drolet","year":"2013","journal-title":"J Pediatr"},{"key":"2024121115404884000_hem2024000597C9","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-14-146","article-title":"Clinical analysis of Kasabach-Merritt syndrome in 17 neonates","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Pediatr"},{"issue":"20","key":"2024121115404884000_hem2024000597C10","doi-asserted-by":"crossref","first-page":"e3431","DOI":"10.1097\/MD.0000000000003431","article-title":"Clinical outcomes for systemic corticosteroids versus vincristine in treating kaposiform hemangioendothelioma and tufted angioma","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine"},{"issue":"8","key":"2024121115404884000_hem2024000597C11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/MPH.0b013e318298ae9e","article-title":"Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey","volume":"35","author":"Tlougan","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"2024121115404884000_hem2024000597C12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/014107689308600418","article-title":"Kasabach-Merritt syndrome exacerbated by platelet transfusion","volume":"86","author":"Phillips","year":"1993","journal-title":"J R Soc Med"},{"issue":"2","key":"2024121115404884000_hem2024000597C13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jpeds.2013.10.013","article-title":"Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly","volume":"164","author":"Croteau","year":"2014","journal-title":"J Pediatr"},{"issue":"1","key":"2024121115404884000_hem2024000597C14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13023-019-1147-9","article-title":"Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences","volume":"14","author":"Ji","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"2024121115404884000_hem2024000597C15","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41436-018-0390-0","article-title":"A somatic activating NRAS variant associated with kaposiform lymphangiomatosis","volume":"21","author":"Barclay","year":"2019","journal-title":"Genet Med"},{"issue":"1","key":"2024121115404884000_hem2024000597C16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10456-016-9537-2","article-title":"Angiopoietins as serum biomarkers for lymphatic anomalies","volume":"20","author":"Le Cras","year":"2017","journal-title":"Angiogenesis"},{"issue":"5","key":"2024121115404884000_hem2024000597C17","doi-asserted-by":"crossref","first-page":"e30921","DOI":"10.1002\/pbc.30921","article-title":"How we use angiopoietin-2 in the diagnosis and management of vascular anomalies","volume":"71","author":"Engel","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2024121115404884000_hem2024000597C18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archderm.140.5.599","article-title":"Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinicopathological entity","volume":"140","author":"North","year":"2004","journal-title":"Arch Dermatol"},{"issue":"6","key":"2024121115404884000_hem2024000597C19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1365-2133.2008.08546.x","article-title":"Rapidly involuting congenital haemangioma associated with transient thrombocytopenia and coagulopathy: a case series","volume":"158","author":"Baselga","year":"2008","journal-title":"Br J Dermatol"},{"issue":"7","key":"2024121115404884000_hem2024000597C20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archderm.144.7.873","article-title":"Association of localized intravascular coagulopathy with venous malformations","volume":"144","author":"Dompmartin","year":"2008","journal-title":"Arch Dermatol"},{"issue":"2","key":"2024121115404884000_hem2024000597C21","doi-asserted-by":"crossref","first-page":"e28824","DOI":"10.1002\/pbc.28824","article-title":"Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography","volume":"68","author":"Mack","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2024121115404884000_hem2024000597C22","doi-asserted-by":"crossref","first-page":"e27896","DOI":"10.1002\/pbc.27896","article-title":"Effect of sirolimus on coagulopathy of slow-flow vascular malformations","volume":"66","author":"Mack","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2024121115404884000_hem2024000597C23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1258\/phleb.2009.009041","article-title":"Venous malformation: update on aetiopathogenesis, diagnosis and management","volume":"25","author":"Dompmartin","year":"2010","journal-title":"Phlebology"},{"issue":"5","key":"2024121115404884000_hem2024000597C24","doi-asserted-by":"crossref","first-page":"150966","DOI":"10.1016\/j.sempedsurg.2020.150966","article-title":"Coagulation issues in vascular anomalies","volume":"29","author":"Ricci","year":"2020","journal-title":"Semin Pediatr Surg"},{"issue":"12","key":"2024121115404884000_hem2024000597C25","doi-asserted-by":"crossref","DOI":"10.3390\/biom12121840","article-title":"Comprehensive analyses of coagulation parameters in patients with vascular anomalies","volume":"12","author":"Kapp","year":"2022","journal-title":"Biomolecules"},{"issue":"10","key":"2024121115404884000_hem2024000597C26","doi-asserted-by":"crossref","first-page":"e28277","DOI":"10.1002\/pbc.28277","article-title":"Retrospective study of hematologic complications in patients with slow-flow vascular malformations undergoing sclerotherapy","volume":"67","author":"Ricci","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2024121115404884000_hem2024000597C27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jpedsurg.2016.10.048","article-title":"Factors associated with thrombotic complications in pediatric patients with vascular malformations","volume":"52","author":"Sep\u00falveda","year":"2017","journal-title":"J Pediatr Surg"},{"issue":"suppl 3","key":"2024121115404884000_hem2024000597C28","doi-asserted-by":"crossref","first-page":"e29353","DOI":"10.1002\/pbc.29353","article-title":"How we approach coagulopathy with vascular anomalies","volume":"69","author":"Mack","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2024121115404884000_hem2024000597C29","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/lary.29123","article-title":"Peri-procedural anticoagulation in patients with head and neck versus extremity venous malformations","volume":"131","author":"Dharmarajan","year":"2021","journal-title":"Laryngoscope"},{"issue":"5","key":"2024121115404884000_hem2024000597C30","doi-asserted-by":"crossref","first-page":"e29610","DOI":"10.1002\/pbc.29610","article-title":"Coagulopathy and related complications following sclerotherapy of congenital venous malformations","volume":"69","author":"Swerdlin","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2024121115404884000_hem2024000597C31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/lrb.2017.0029","article-title":"Effectiveness and safety of treatment with direct oral anticoagulant rivaroxaban in patients with slow-flow vascular malformations: a case series","volume":"16","author":"Mack","year":"2018","journal-title":"Lymphat Res Biol"},{"issue":"3","key":"2024121115404884000_hem2024000597C32","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1542\/peds.2004-0446","article-title":"Evaluation and management of pain in patients with Klippel-Trenaunay syndrome: a review","volume":"115","author":"Lee","year":"2005","journal-title":"Pediatrics"},{"issue":"5","key":"2024121115404884000_hem2024000597C33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/pde.12373","article-title":"Aspirin therapy in venous malformation: a retrospective cohort study of benefits, side effects, and patient experiences","volume":"31","author":"Nguyen","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"S2","key":"2024121115404884000_hem2024000597C34","first-page":"s92","article-title":"Anticoagulation effects on quality of life in patients with slow-flow vascular malformations","volume":"71","author":"Mack","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"2024121115404884000_hem2024000597C35","first-page":"328","article-title":"Venous thrombosis and coagulation parameters in patients with pure venous malformations","volume":"75","author":"van Es","year":"2017","journal-title":"Neth J Med"},{"issue":"5","key":"2024121115404884000_hem2024000597C36","first-page":"246","article-title":"Venous thromboembolism and prothrombotic parameters in Klippel-Trenaunay syndrome","volume":"71","author":"Oduber","year":"2013","journal-title":"Neth J Med"},{"issue":"5","key":"2024121115404884000_hem2024000597C37","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jaad.2020.07.019","article-title":"Aberrant venous anatomy as a risk factor for thromboembolic events in patients with Klippel-Tr\u00e9naunay syndrome: case-control study within a cohort study","volume":"84","author":"Zwerink","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2024121115404884000_hem2024000597C38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaad.2006.08.057","article-title":"New techniques for the evaluation and therapeutic planning of patients with Klippel-Tr\u00e9naunay syndrome","volume":"56","author":"Bastarrika","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2024121115404884000_hem2024000597C39","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/RCT.0000000000000895","article-title":"Imaging findings of Klippel-Trenaunay syndrome","volume":"43","author":"Abdel Razek","year":"2019","journal-title":"J Comput Assist Tomogr"},{"issue":"4","key":"2024121115404884000_hem2024000597C40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1358863X13498463","article-title":"The persistent embryonic vein in Klippel-Trenaunay syndrome","volume":"18","author":"Oduber","year":"2013","journal-title":"Vasc Med"},{"issue":"4","key":"2024121115404884000_hem2024000597C41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jvsv.2018.01.015","article-title":"Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal\/skeletal abnormalities and Klippel-Trenaunay syndrome","volume":"6","author":"Reis J","year":"2018","journal-title":"J Vasc Surg Venous Lymphat Disord"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/718\/2346724\/718crary.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/718\/2346724\/718crary.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T20:09:20Z","timestamp":1733947760000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2024\/1\/718\/526204\/Hemostasis-and-thrombosis-risks-and-management-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12,6]]},"published-print":{"date-parts":[[2024,12,6]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2024000597","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12,6]]},"published":{"date-parts":[[2024,12,6]]}}}